查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1830901

2025年全球體細胞基因檢測市場報告

Somatic Genetic Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，體細胞基因檢測市場發展迅速，預計從2024年的68.1億美元成長到2025年的77.8億美元，複合年成長率達14.3%。這一成長可歸因於人們對遺傳疾病的認知不斷提高、癌症發病率上升、臨床環境中基因檢測的普及、醫療基礎設施的擴建以及患者對個人化治療需求的增加。

預計未來幾年體細胞基因檢測市場將快速成長，到2029年市場規模將達到131.3億美元，年複合成長率（CAGR）為14.0%。預測期內的成長可歸因於對疾病早期檢測的日益重視、生物技術公司和製藥公司之間合作的加強、官民合作關係的增多以及先進診斷工具的日益普及。這段時期的主要趨勢包括定序技術的進步、生物資訊學和人工智慧的創新、研發投入的增加、非侵入性檢測方法的進步以及次世代定序平台的持續創新。

體細胞基因檢測是對人類一生中非生殖細胞（體細胞）中發生的基因突變進行全面分析，其中許多突變發生在腫瘤組織中。體細胞基因檢測透過檢測可作為個人化治療標靶的特定基因改變，以及預測疾病進展和支持臨床決策，在癌症診斷和治療中發揮重要作用。

體細胞基因檢測的主要類型包括標靶基因panel檢測、全外EXOME定序、全基因測序和帶因者篩檢。標靶基因panel檢測透過分析與特定疾病或病症相關的特定基因集，實現準確且經濟高效的診斷。這些檢測可使用多種樣本類型，包括組織樣本、血液樣本和骨髓穿刺液。它們採用聚合酵素鏈鎖反應(PCR)、次世代定序(NGS)、微陣列和桑格定序等先進技術。這些檢測應用於癌症診斷、心血管疾病、神經系統疾病和遺傳性疾病等多個領域，並被醫院、臨床實驗室、研究機構和家庭檢測服務提供者等終端用戶所使用。

美國2025年突然提高關稅及其引發的貿易摩擦正對製藥公司造成嚴重衝擊。利潤豐厚的學名藥生產商尤其脆弱，一些公司不得不縮減低利潤藥物的生產規模。生物技術公司也因關稅導致的專用試劑短缺而面臨臨床試驗延期。為因應這一局面，製藥業正在印度和歐洲擴大原料藥的生產，增加庫存，並遊說政府對基本藥物給予貿易豁免。

這份體細胞基因檢測市場研究報告是商業研究公司最新報告系列的一部分，提供體細胞基因檢測市場統計數據，包括全球市場規模、區域佔有率、競爭對手及其市場佔有率、詳細的市場細分、市場趨勢以及體細胞基因檢測行業的商機。本市場研究報告對該行業的現狀和未來發展趨勢進行了深入分析，為您提供所需的一切全面觀點。

預計未來幾年癌症發生率的上升將推動體細胞基因檢測市場的成長。癌症是一組以體內異常細胞不受控制地生長和擴散為特徵的疾病。癌症負擔的加重與不健康的飲食、吸煙、缺乏運動和過量飲酒等生活方式因素密切相關。體細胞基因檢測透過識別腫瘤特異性基因突變來輔助癌症診斷，從而實現標靶和個人化的治療策略。先進技術還能減少侵入性手術的需求，提高診斷準確性，並改善病患預後。例如，澳洲政府機構—澳洲健康與福利研究所（Australian Institute of Health and Welfare）於2024年7月報告稱，2022年澳洲確診癌症患者人數達到160,570人，比2021年的156,781人增加了3,789人。因此，癌症發生率的上升正在刺激對體細胞基因檢測的需求。

體細胞基因檢測市場的企業正致力於開發先進的診斷解決方案，例如液態切片活體組織切片，以提高檢測準確性、實現早期發現並減少對侵入性操作的依賴。液態切片是一種非侵入性方法，用於分析血液樣本中的循環腫瘤DNA (ctDNA) 和其他生物標記物，以識別癌症相關的基因突變。例如，2024年9月，印度基因組學和生物資訊學公司Strand Life Sciences推出了Somatic Advantage 74液體活體組織切片 (SA74 LB) 檢測，這是一種基於新一代次世代定序儀(NGS) 的解決方案，旨在檢測血液樣本中的ctDNA。此檢測可識別74個關鍵癌症相關基因中的體細胞突變，透過精確定位可操作的突變、監測治療反應以及檢測微量殘存疾病(MRD)，無需傳統的組織切片檢查，從而支持個人化癌症治療。此外，它還能指導標靶治療並即時追蹤疾病進展和抗藥性，從而推動精準腫瘤學的發展。

2022年12月，中國基因檢測公司普瑞納斯環球有限公司（Prenetics Global Limited）收購了ACT Genomics Holdings Company，具體金額未揭露。此次收購使普瑞納斯環球有限公司獲得了ACT Genomics的癌症檢測技術，包括新一代定序（NGS）、生物資訊學和基因組分析，從而增強了細胞株和細胞株檢測能力。總部位於台灣的ACT Genomics Holdings Company Limited專注於為癌症患者提供體細胞基因檢測服務。

體細胞基因檢測市場由提供腫瘤譜分析、生物標記鑑定、伴隨診斷檢測、突變分析以及用於個人化癌症治療方案選擇和治療監測的次世代定序(NGS) 等服務的營業單位所獲得的收入組成。市場價值包括服務供應商銷售的任何相關產品或包含在其服務產品中的任何相關產品的價值。體細胞基因檢測市場還包括用於檢測和解讀體細胞突變的檢測套組、試劑、檢測組合、定序儀、數據分析軟體工具和實驗室耗材的銷售。該市場的價值為“出廠價”，即產品製造商或創建者銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的產品價值。該市場的產品價值還包括產品創建者銷售的任何相關服務的價值。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球體細胞基因檢測：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 終端用戶產業分析
  • 全球體細胞基因檢測市場：成長率分析
  • 全球體細胞基因檢測市場表現：規模與成長，2019-2024年
  • 全球體細胞基因檢測市場預測：規模與成長，2024-2029年，2034年
  • 全球體細胞基因檢測：潛在市場規模（TAM）

第6章 市場細分

  • 全球體細胞基因檢測市場按類型、效能和預測分類，2019-2024年、2024-2029年、2034年
  • 標靶基因檢測
  • 全EXOME定序
  • 全基因測序
  • 攜帶者篩檢
  • 其他
  • 全球體細胞基因檢測市場：依樣本類型、表現及預測分類，2019-2024年、2024-2029年、2034年
  • 組織
  • 血
  • 骨髓穿刺液
  • 其他
  • 全球體細胞基因檢測市場：依技術、效能和預測分類，2019-2024年、2024-2029年、2034年
  • 聚合酵素鏈鎖反應（PCR）
  • 次世代定序（NGS）
  • 微陣列
  • 桑格定序
  • 其他
  • 全球體細胞基因檢測市場：依應用、效能和預測分類，2019-2024年、2024-2029年、2034年
  • 癌症診斷
  • 心血管疾病
  • 神經系統疾病
  • 遺傳性疾病
  • 其他
  • 全球體細胞基因檢測市場依最終用戶、效能和預測分類，2019-2024年、2024-2029年、2034年
  • 醫院
  • 臨床實驗室
  • 研究所
  • 居家檢測服務提供者
  • 其他
  • 全球體細胞基因檢測市場：靶向基因panel細分市場，按類型、性能和預測（2019-2024年、2024-2029年、2034年）
  • 腫瘤專家組
  • 神經科專家組
  • 心血管專家組
  • 罕見疾病專家組
  • 藥物基因組學小組
  • 全球體細胞基因檢測市場：全EXOME定序細分市場，按類型、表現和預測，2019-2024年、2024-2029年、2034年
  • 診斷性全EXOME定序
  • 全外EXOME定序在臨床研究的應用
  • 基於人群的全EXOME定序
  • 全球體細胞基因檢測市場：全基因測序細分市場，按類型、表現和預測，2019-2024年、2024-2029年、2034年
  • 臨床全基因測序
  • 全基因測序研究
  • De Novo 全基因測序
  • 癌症全基因測序
  • 全球體細胞基因檢測市場：帶因者篩檢細分市場，按類型、表現和預測（2019-2024年、2024-2029年、2034年）
  • 擴大攜帶者篩檢
  • 基於種族的攜帶者篩檢
  • 普遍攜帶者篩檢
  • 全球體細胞基因檢測市場：其他細分市場、按類型分類、實際結果和預測（2019-2024年、2024-2029年、2034年）
  • 拷貝數變異測試
  • 粒線體去氧核糖核酸（DNA）檢測
  • 核糖核酸（RNA）定序
  • 表觀遺傳學檢測

第7章 區域和國家分析

  • 全球體細胞基因檢測市場：依地區、績效及預測分類，2019-2024年、2024-2029年、2034年
  • 全球體細胞基因檢測市場：國家、市場表現及預測，2019-2024年、2024-2029年、2034年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 體細胞基因檢測市場：競爭格局
  • 體細胞基因檢測市場：公司概況
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
    • Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Illumina Inc.
  • QIAGEN NV
  • Exact Sciences Corp.
  • ARUP Laboratories Inc.
  • Natera Inc.
  • Myriad Genetics Inc.
  • Fulgent Genetics Inc.
  • Invitae Corporation
  • NeoGenomics Laboratories Inc.
  • Guardant Health Inc.
  • MedGenome Labs Ltd.
  • Caris Life Sciences Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California Inc.
  • Invivoscribe Inc.

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 2029年體細胞基因檢測市場：提供新機會的國家
  • 2029年體細胞基因檢測市場：新興細分市場機會
  • 2029年體細胞基因檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r37892

Somatic genetic testing refers to the comprehensive analysis of genetic mutations that occur in non-reproductive (somatic) cells over a person's lifetime, most often within tumor tissues. It plays a vital role in cancer diagnosis and treatment by detecting specific genetic alterations that can be targeted with personalized therapies, while also helping to predict disease progression and support clinical decision-making.

The key types of somatic genetic testing include targeted gene panels, whole exome sequencing, whole genome sequencing, carrier screening, and others. Targeted gene panels involve analyzing a defined group of genes linked to a particular disease or condition, allowing for accurate and cost-effective diagnosis. This testing can be performed using a range of sample types, such as tissue-based samples, blood samples, bone marrow aspirates, and others. It employs advanced technologies including polymerase chain reaction (PCR), next-generation sequencing (NGS), microarray, Sanger sequencing, and more. Somatic genetic testing is applied in various areas such as cancer diagnosis, cardiovascular diseases, neurological disorders, inherited genetic conditions, and others, and is utilized by end users including hospitals, clinical laboratories, research institutes, at-home testing providers, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The somatic genetic testing market research report is one of a series of new reports from The Business Research Company that provides somatic genetic testing market statistics, including somatic genetic testing industry global market size, regional shares, competitors with a somatic genetic testing market share, detailed somatic genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the somatic genetic testing industry. This somatic genetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The somatic genetic testing market size has grown rapidly in recent years. It will grow from $6.81 billion in 2024 to $7.78 billion in 2025 at a compound annual growth rate (CAGR) of 14.3%. The growth during the historic period can be attributed to increasing awareness of genetic disorders, the rising prevalence of cancer, greater adoption of genetic testing in clinical settings, the expansion of healthcare infrastructure, and growing patient demand for personalized treatment.

The somatic genetic testing market size is expected to see rapid growth in the next few years. It will grow to $13.13 billion in 2029 at a compound annual growth rate (CAGR) of 14.0%. The growth in the forecast period can be attributed to the increasing focus on early disease detection, rising collaborations between biotechnology and pharmaceutical companies, the expansion of public-private partnerships, and greater availability of advanced diagnostic tools. Key trends expected during this period include technological progress in sequencing, innovations in bioinformatics and artificial intelligence, increased investment in research and development, the advancement of non-invasive testing methods, and continued innovations in next-generation sequencing platforms.

The rising incidence of cancer is expected to drive the growth of the somatic genetic testing market in the coming years. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. The increasing burden of cancer is linked to lifestyle factors such as unhealthy diets, smoking, physical inactivity, and excessive alcohol consumption. Somatic genetic testing supports cancer diagnosis by identifying tumor-specific genetic mutations, enabling targeted and personalized treatment strategies. It also reduces the need for invasive procedures through advanced technologies, enhancing diagnostic accuracy and improving patient outcomes. For example, in July 2024, the Australian Institute of Health and Welfare, a government agency, reported that the number of cancer cases diagnosed in Australia reached 160,570 in 2022, an increase of 3,789 cases from 156,781 in 2021. Consequently, the growing incidence of cancer is fueling demand for somatic genetic testing.

Companies in the somatic genetic testing market are focusing on advanced diagnostic solutions such as liquid biopsy tests to improve precision, enable early detection, and reduce reliance on invasive procedures. Liquid biopsy refers to a non-invasive method of analyzing circulating tumor DNA (ctDNA) or other biomarkers in blood samples to identify cancer-related genetic mutations. For instance, in September 2024, Strand Life Sciences, an India-based genomics and bioinformatics company, introduced the Somatic Advantage 74 Liquid Biopsy (SA74 LB) test, a next-generation sequencing (NGS)-based solution designed to detect ctDNA from blood samples. This test identifies somatic mutations across 74 key cancer-related genes, supporting personalized cancer care by pinpointing actionable mutations, monitoring treatment response, and detecting minimal residual disease (MRD) without traditional tissue biopsies. It facilitates precision oncology by guiding targeted therapies and tracking disease progression or resistance in real time.

In December 2022, Prenetics Global Limited, a China-based genetic testing company, acquired ACT Genomics Holdings Company Limited for an undisclosed sum. Through this acquisition, Prenetics gains access to ACT Genomics' cancer testing technologies, including NGS, bioinformatics, and genome profiling, to enhance both somatic and germline testing across Asia and beyond. ACT Genomics Holdings Company Limited, based in Taiwan, specializes in somatic genetic testing for cancer patients.

Major players in the somatic genetic testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Exact Sciences Corp., ARUP Laboratories Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., MedGenome Labs Ltd., Caris Life Sciences Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Invivoscribe Inc., Centogene N.V., and Circulogene Theranostics LLC.

North America was the largest region in the somatic genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in somatic genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the somatic genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The somatic genetic testing market consists of revenues earned by entities by providing services such as tumor profiling, biomarker identification, companion diagnostic testing, mutation analysis, and next-generation sequencing (NGS) for personalized cancer therapy selection and treatment monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The somatic genetic testing market also includes sales of testing kits, reagents, assay panels, sequencing instruments, software tools for data analysis, and laboratory consumables used in the detection and interpretation of somatic mutations. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Somatic Genetic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on somatic genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for somatic genetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The somatic genetic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Targeted Gene Panels; Whole Exome Sequencing; Whole Genome Sequencing; Carrier Screening; Other Testing Methods
  • 2) By Sample: Tissue-Based; Blood-Based; Bone Marrow Aspirates; Other Samples
  • 3) By Technology: Polymerase Chain Reaction (PCR); Next-Generation Sequencing (NGS); Microarray; Sanger Sequencing; Other Technologies
  • 4) By Application: Cancer Diagnosis; Cardiovascular Disorders; Neurological Disorders; Inherited Genetic Disorders; Other Applications
  • 5) By End-User: Hospitals; Clinical Laboratories; Research Institutes; At-Home Testing Providers; Other End-Users
  • Subsegments:
  • 1) By Targeted Gene Panels: Oncology Panels; Neurology Panels; Cardiovascular Panels; Rare Disease Panels; Pharmacogenomics Panels
  • 2) By Whole Exome Sequencing: Diagnostic Whole Exome Sequencing; Clinical Research Whole Exome Sequencing; Population-Based Whole Exome Sequencing
  • 3) By Whole Genome Sequencing: Clinical Whole Genome Sequencing; Research Whole Genome Sequencing; De Novo Whole Genome Sequencing; Cancer Whole Genome Sequencing
  • 4) By Carrier Screening: Expanded Carrier Screening; Ethnicity-Based Carrier Screening; Universal Carrier Screening
  • 5) By Other Testing Methods: Copy Number Variation Testing; Mitochondrial Deoxyribonucleic Acid (DNA) Testing; Ribonucleic Acid (RNA) Sequencing; Epigenetic Testing
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Agilent Technologies Inc.; Illumina Inc.; QIAGEN N.V.; Exact Sciences Corp.; ARUP Laboratories Inc.; Natera Inc.; Myriad Genetics Inc.; Fulgent Genetics Inc.; Invitae Corporation; NeoGenomics Laboratories Inc.; Guardant Health Inc.; MedGenome Labs Ltd.; Caris Life Sciences Inc.; Oxford Nanopore Technologies Ltd.; Pacific Biosciences of California Inc.; Invivoscribe Inc.; Centogene N.V.; Circulogene Theranostics LLC.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Somatic Genetic Testing Market Characteristics

3. Somatic Genetic Testing Market Trends And Strategies

4. Somatic Genetic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Somatic Genetic Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Somatic Genetic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Somatic Genetic Testing Market Growth Rate Analysis
  • 5.4. Global Somatic Genetic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Somatic Genetic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Somatic Genetic Testing Total Addressable Market (TAM)

6. Somatic Genetic Testing Market Segmentation

  • 6.1. Global Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Targeted Gene Panels
  • Whole Exome Sequencing
  • Whole Genome Sequencing
  • Carrier Screening
  • Other Testing Methods
  • 6.2. Global Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tissue-Based
  • Blood-Based
  • Bone Marrow Aspirates
  • Other Samples
  • 6.3. Global Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction (PCR)
  • Next-Generation Sequencing (NGS)
  • Microarray
  • Sanger Sequencing
  • Other Technologies
  • 6.4. Global Somatic Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer Diagnosis
  • Cardiovascular Disorders
  • Neurological Disorders
  • Inherited Genetic Disorders
  • Other Applications
  • 6.5. Global Somatic Genetic Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinical Laboratories
  • Research Institutes
  • At-Home Testing Providers
  • Other End-Users
  • 6.6. Global Somatic Genetic Testing Market, Sub-Segmentation Of Targeted Gene Panels, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology Panels
  • Neurology Panels
  • Cardiovascular Panels
  • Rare Disease Panels
  • Pharmacogenomics Panels
  • 6.7. Global Somatic Genetic Testing Market, Sub-Segmentation Of Whole Exome Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Whole Exome Sequencing
  • Clinical Research Whole Exome Sequencing
  • Population-Based Whole Exome Sequencing
  • 6.8. Global Somatic Genetic Testing Market, Sub-Segmentation Of Whole Genome Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinical Whole Genome Sequencing
  • Research Whole Genome Sequencing
  • De Novo Whole Genome Sequencing
  • Cancer Whole Genome Sequencing
  • 6.9. Global Somatic Genetic Testing Market, Sub-Segmentation Of Carrier Screening, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Expanded Carrier Screening
  • Ethnicity-Based Carrier Screening
  • Universal Carrier Screening
  • 6.10. Global Somatic Genetic Testing Market, Sub-Segmentation Of Other Testing Methods, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Copy Number Variation Testing
  • Mitochondrial Deoxyribonucleic Acid (DNA) Testing
  • Ribonucleic Acid (RNA) Sequencing
  • Epigenetic Testing

7. Somatic Genetic Testing Market Regional And Country Analysis

  • 7.1. Global Somatic Genetic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Somatic Genetic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Somatic Genetic Testing Market

  • 8.1. Asia-Pacific Somatic Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Somatic Genetic Testing Market

  • 9.1. China Somatic Genetic Testing Market Overview
  • 9.2. China Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Somatic Genetic Testing Market

  • 10.1. India Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Somatic Genetic Testing Market

  • 11.1. Japan Somatic Genetic Testing Market Overview
  • 11.2. Japan Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Somatic Genetic Testing Market

  • 12.1. Australia Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Somatic Genetic Testing Market

  • 13.1. Indonesia Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Somatic Genetic Testing Market

  • 14.1. South Korea Somatic Genetic Testing Market Overview
  • 14.2. South Korea Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Somatic Genetic Testing Market

  • 15.1. Western Europe Somatic Genetic Testing Market Overview
  • 15.2. Western Europe Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Somatic Genetic Testing Market

  • 16.1. UK Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Somatic Genetic Testing Market

  • 17.1. Germany Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Somatic Genetic Testing Market

  • 18.1. France Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Somatic Genetic Testing Market

  • 19.1. Italy Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Somatic Genetic Testing Market

  • 20.1. Spain Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Somatic Genetic Testing Market

  • 21.1. Eastern Europe Somatic Genetic Testing Market Overview
  • 21.2. Eastern Europe Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Somatic Genetic Testing Market

  • 22.1. Russia Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Somatic Genetic Testing Market

  • 23.1. North America Somatic Genetic Testing Market Overview
  • 23.2. North America Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Somatic Genetic Testing Market

  • 24.1. USA Somatic Genetic Testing Market Overview
  • 24.2. USA Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Somatic Genetic Testing Market

  • 25.1. Canada Somatic Genetic Testing Market Overview
  • 25.2. Canada Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Somatic Genetic Testing Market

  • 26.1. South America Somatic Genetic Testing Market Overview
  • 26.2. South America Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Somatic Genetic Testing Market

  • 27.1. Brazil Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Somatic Genetic Testing Market

  • 28.1. Middle East Somatic Genetic Testing Market Overview
  • 28.2. Middle East Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Somatic Genetic Testing Market

  • 29.1. Africa Somatic Genetic Testing Market Overview
  • 29.2. Africa Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Somatic Genetic Testing Market Competitive Landscape And Company Profiles

  • 30.1. Somatic Genetic Testing Market Competitive Landscape
  • 30.2. Somatic Genetic Testing Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Somatic Genetic Testing Market Other Major And Innovative Companies

  • 31.1. Illumina Inc.
  • 31.2. QIAGEN N.V.
  • 31.3. Exact Sciences Corp.
  • 31.4. ARUP Laboratories Inc.
  • 31.5. Natera Inc.
  • 31.6. Myriad Genetics Inc.
  • 31.7. Fulgent Genetics Inc.
  • 31.8. Invitae Corporation
  • 31.9. NeoGenomics Laboratories Inc.
  • 31.10. Guardant Health Inc.
  • 31.11. MedGenome Labs Ltd.
  • 31.12. Caris Life Sciences Inc.
  • 31.13. Oxford Nanopore Technologies Ltd.
  • 31.14. Pacific Biosciences of California Inc.
  • 31.15. Invivoscribe Inc.

32. Global Somatic Genetic Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Somatic Genetic Testing Market

34. Recent Developments In The Somatic Genetic Testing Market

35. Somatic Genetic Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Somatic Genetic Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Somatic Genetic Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Somatic Genetic Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer